{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:58:41Z","timestamp":1790240321850,"version":"4.1.0"},"reference-count":63,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,6,1]]},"abstract":"<jats:p>BCR\/ABL fluorescent in situ hybridization study of chronic myeloid leukemia (CML) and Philadelphia+(Ph+) acute lymphoid leukemia (ALL) indicated that approximately 9% of patients exhibited an atypical hybridization pattern consistent with a submicroscopic deletion of the 5\u2032 region ofABL and the 3\u2032 region of the BCR genes on the 9q+ chromosome. The CML patients with deletions had a shorter survival time and a high relapse rate following bone marrow transplant. Since deletions are associated with both Ph+CML and ALL, it seemed probable that other leukemia-associated genomic rearrangements may also have submicroscopic deletions. This hypothesis was confirmed by the detection of deletions of the 3\u2032 regions of theCBFB and the MLL genes in AML M4 patients with inv(16) and in patients with ALL and AML associated withMLL gene translocations, respectively. In contrast, analysis of the AML M3 group of patients and AML M2 showed that similar large deletions were not frequently associated with the t(15;17) or t(8;21) translocations. Analysis of sequence data from each of the breakpoint regions suggested that large submicroscopic deletions occur in regions with a high overall density of Alu sequence repeats. These findings are the first to show that the process of deletion formation is not disease specific in leukemia and also implicate that the presence of repetitive DNA in the vicinity of breakpoint regions may facilitate the generation of submicroscopic deletions. Such deletions could lead to the loss of one or more genes, and the associated haploinsufficiency may result in the observed differences in clinical behavior.<\/jats:p>","DOI":"10.1182\/blood.v97.11.3581","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T08:46:47Z","timestamp":1027759607000},"page":"3581-3588","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":177,"title":["Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis"],"prefix":"10.1182","volume":"97","author":[{"given":"Elena","family":"Kolomietz","sequence":"first","affiliation":[{"name":"From the Ontario Cancer Institute, Princess Margaret Hospital, Toronto General Hospital, University Health Network, Department of Laboratory Medicine and Pathobiology, Medical Biophysics, and Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaudah","family":"Al-Maghrabi","sequence":"additional","affiliation":[{"name":"From the Ontario Cancer Institute, Princess Margaret Hospital, Toronto General Hospital, University Health Network, Department of Laboratory Medicine and Pathobiology, Medical Biophysics, and Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Brennan","sequence":"additional","affiliation":[{"name":"From the Ontario Cancer Institute, Princess Margaret Hospital, Toronto General Hospital, University Health Network, Department of Laboratory Medicine and Pathobiology, Medical Biophysics, and Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Karaskova","sequence":"additional","affiliation":[{"name":"From the Ontario Cancer Institute, Princess Margaret Hospital, Toronto General Hospital, University Health Network, Department of Laboratory Medicine and Pathobiology, Medical Biophysics, and Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Minkin","sequence":"additional","affiliation":[{"name":"From the Ontario Cancer Institute, Princess Margaret Hospital, Toronto General Hospital, University Health Network, Department of Laboratory Medicine and Pathobiology, Medical Biophysics, and Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lipton","sequence":"additional","affiliation":[{"name":"From the Ontario Cancer Institute, Princess Margaret Hospital, Toronto General Hospital, University Health Network, Department of Laboratory Medicine and Pathobiology, Medical Biophysics, and Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy A.","family":"Squire","sequence":"additional","affiliation":[{"name":"From the Ontario Cancer Institute, Princess Margaret Hospital, Toronto General Hospital, University Health Network, Department of Laboratory Medicine and Pathobiology, Medical Biophysics, and Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021217460643900_B1"},{"key":"2020021217460643900_B2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00062752-199807000-00010","article-title":"Chronic myeloid leukemia.","volume":"5","author":"Deininger","year":"1998","journal-title":"Curr Opin Hematol."},{"key":"2020021217460643900_B3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1182\/blood.V95.3.738.003k21_738_743","article-title":"Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia.","volume":"95","author":"Sinclair","year":"2000","journal-title":"Blood."},{"key":"2020021217460643900_B4","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood.V92.7.2315","article-title":"A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia.","volume":"92","author":"Buno","year":"1998","journal-title":"Blood."},{"key":"2020021217460643900_B5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1182\/blood.V85.3.772.bloodjournal853772","article-title":"Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis.","volume":"85","author":"Marlton","year":"1995","journal-title":"Blood."},{"key":"2020021217460643900_B6","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.leu.2400681","article-title":"Detection of 16 p deletions by FISH in patients with inv(16) or t(16;16) and acute myeloid leukemia (AML).","volume":"11","author":"Martinet","year":"1997","journal-title":"Leukemia."},{"key":"2020021217460643900_B7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0959-437X(99)00031-3","article-title":"Interspersed repeats and other mementos of transposable elements in mammalian genomes.","volume":"9","author":"Smit","year":"1999","journal-title":"Curr Opin Genet Dev."},{"key":"2020021217460643900_B8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0092-8674(00)81148-4","article-title":"Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1.","volume":"93","author":"Jin","year":"1998","journal-title":"Cell."},{"key":"2020021217460643900_B9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00000478-199809000-00007","article-title":"Atypical teratoid\/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study.","volume":"22","author":"Burger","year":"1998","journal-title":"Am J Surg Pathol."},{"key":"2020021217460643900_B10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3171\/jns.1990.73.5.0710","article-title":"Monosomy 22 in rhabdoid or atypical tumors of the brain.","volume":"73","author":"Biegel","year":"1990","journal-title":"J Neurosurg."},{"key":"2020021217460643900_B11","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/hmg\/8.13.2359","article-title":"Spectrum of hSNF5\/INI1 somatic mutations in human cancer and genotype-phenotype correlations.","volume":"8","author":"Sevenet","year":"1999","journal-title":"Hum Mol Genet."},{"key":"2020021217460643900_B12","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/nar\/23.7.1127","article-title":"A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm.","volume":"23","author":"Muchardt","year":"1995","journal-title":"Nucleic Acids Res."},{"key":"2020021217460643900_B13","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1101\/gad.10.17.2117","article-title":"Diversity and specialization of mammalian SWI\/SNF complexes.","volume":"10","author":"Wang","year":"1996","journal-title":"Genes Dev."},{"key":"2020021217460643900_B14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/28212","article-title":"Truncating mutations of hSNF5\/INI1 in aggressive paediatric cancer.","volume":"394","author":"Versteege","year":"1998","journal-title":"Nature."},{"key":"2020021217460643900_B15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/38525","article-title":"A model for p53-induced apoptosis.","volume":"389","author":"Polyak","year":"1997","journal-title":"Nature."},{"key":"2020021217460643900_B16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1634\/theoncologist.5-5-405","article-title":"Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis [In Process Citation].","volume":"5","author":"Di Bacco","year":"2000","journal-title":"Oncologist."},{"key":"2020021217460643900_B17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/10428199709042502","article-title":"Apoptosis in chronic myelogenous leukemia: studies of stage-specific differences.","volume":"25","author":"Gisslinger","year":"1997","journal-title":"Leuk Lymphoma."},{"key":"2020021217460643900_B18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.onc.1201490","article-title":"BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner.","volume":"16","author":"Cambier","year":"1998","journal-title":"Oncogene."},{"key":"2020021217460643900_B19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0960-9822(06)00219-3","article-title":"A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton.","volume":"7","author":"Aspenstrom","year":"1997","journal-title":"Curr Biol."},{"key":"2020021217460643900_B20","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0301-472X(99)00084-3","article-title":"Role of abnormal integrin-cytoskeletal interactions in impaired beta1 integrin function in chronic myelogenous leukemia hematopoietic progenitors.","volume":"27","author":"Bhatia","year":"1999","journal-title":"Exp Hematol."},{"key":"2020021217460643900_B21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1615\/CritRevOncog.v8.i4.40","article-title":"Role of focal adhesion proteins in signal transduction and oncogenesis.","volume":"8","author":"Weisberg","year":"1997","journal-title":"Crit Rev Oncog."},{"key":"2020021217460643900_B22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI119520","article-title":"BCR\/ABL induces multiple abnormalities of cytoskeletal function.","volume":"100","author":"Salgia","year":"1997","journal-title":"J Clin Invest."},{"key":"2020021217460643900_B23","first-page":"3870","article-title":"Frequent deletion of hSNF5\/INI1, a component of the SWI\/SNF complex, in chronic myeloid leukemia.","volume":"59","author":"Grand","year":"1999","journal-title":"Cancer Res."},{"key":"2020021217460643900_B24","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1182\/blood.V95.11.3514","article-title":"Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity [In Process Citation].","volume":"95","author":"van Der Kolk","year":"2000","journal-title":"Blood."},{"key":"2020021217460643900_B25","doi-asserted-by":"crossref","first-page":"8538","DOI":"10.1073\/pnas.90.18.8538","article-title":"Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.","volume":"90","author":"Corral","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217460643900_B26","first-page":"S1","article-title":"1993 Robert R. deVilliers Lecture. Chromosome translocations: dangerous liaisons.","volume":"8(suppl 1)","author":"Rowley","year":"1994","journal-title":"Leukemia."},{"key":"2020021217460643900_B27","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/sj.leu.2401718","article-title":"Lack of BCR\/ABL reciprocal fusion in variant Philadelphia chromosome translocations: a use of double fusion signal FISH and spectral karyotyping [letter].","volume":"14","author":"Markovic","year":"2000","journal-title":"Leukemia."},{"key":"2020021217460643900_B28","volume-title":"Cancer Cytogenetics.","author":"Heim","year":"1995","edition":"2nd ed."},{"key":"2020021217460643900_B29","first-page":"1","article-title":"Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model.","volume":"2","author":"Tycko","year":"1990","journal-title":"Cancer Cells."},{"key":"2020021217460643900_B30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/hmg\/7.5.767","article-title":"The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia.","volume":"7","author":"Jeffs","year":"1998","journal-title":"Hum Mol Genet."},{"key":"2020021217460643900_B31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s004390050916","article-title":"A large Alu-mediated deletion, identified by PCR, as the molecular basis for glycogen storage disease type II (GSDII).","volume":"104","author":"Huie","year":"1999","journal-title":"Hum Genet."},{"key":"2020021217460643900_B32","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1074\/jbc.272.17.11402","article-title":"The translin ring specifically recognizes DNA ends at recombination hot spots in the human genome.","volume":"272","author":"Kasai","year":"1997","journal-title":"J Biol Chem."},{"key":"2020021217460643900_B33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ng0695-167","article-title":"A novel gene, Translin, encodes a recombination hotspot binding protein associated with chromosomal translocations.","volume":"10","author":"Aoki","year":"1995","journal-title":"Nat Genet."},{"key":"2020021217460643900_B34","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/j.1460-2075.1989.tb08402.x","article-title":"Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours.","volume":"8","author":"Boehm","year":"1989","journal-title":"EMBO J."},{"key":"2020021217460643900_B35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0167-4781(98)00139-0","article-title":"Secondary leukemias induced by topoisomerase-targeted drugs.","volume":"1400","author":"Felix","year":"1998","journal-title":"Biochim Biophys Acta."},{"key":"2020021217460643900_B36","first-page":"265","article-title":"Chromosome breakage and recombination at fragile sites.","volume":"43","author":"Glover","year":"1988","journal-title":"Am J Hum Genet."},{"key":"2020021217460643900_B37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-4608(92)90091-L","article-title":"Relationship between fragile sites and cancer breakpoints [letter].","volume":"61","author":"Wenger","year":"1992","journal-title":"Cancer Genet Cytogenet."},{"key":"2020021217460643900_B38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/geno.1995.1008","article-title":"Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation.","volume":"27","author":"Chissoe","year":"1995","journal-title":"Genomics."},{"key":"2020021217460643900_B39","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.1995.tb03392.x","article-title":"Characterization of genomic BCR-ABL breakpoints in chronic myeloid leukaemia by PCR.","volume":"90","author":"Zhang","year":"1995","journal-title":"Br J Haematol."},{"key":"2020021217460643900_B40","first-page":"1679","article-title":"DNA sequence analysis of the major breakpoint cluster region of the BCR gene rearranged in Philadelphia-positive human leukemias.","volume":"8","author":"Sowerby","year":"1993","journal-title":"Oncogene."},{"key":"2020021217460643900_B41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/gcc.2870010308","article-title":"Characterization of the translocation breakpoint sequences in Philadelphia-positive acute lymphoblastic leukemia.","volume":"1","author":"Papadopoulos","year":"1990","journal-title":"Genes Chromosomes Cancer."},{"key":"2020021217460643900_B42","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.1093\/nar\/17.19.7631","article-title":"Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias with rearrangements in the BCR gene first intron: further evidence implicating Alu sequences in the chromosome translocation.","volume":"17","author":"Chen","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"2020021217460643900_B43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s004390050822","article-title":"Molecular characterization of two deletion events involving Alu-sequences, one novel base substitution and two tentative hotspot mutations in the hypoxanthine phosphoribosyltransferase (HPRT) gene in five patients with Lesch-Nyhan syndrome.","volume":"103","author":"Tvrdik","year":"1998","journal-title":"Hum Genet."},{"key":"2020021217460643900_B44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0092-8674(83)90331-8","article-title":"The double-strand-break repair model for recombination.","volume":"33","author":"Szostak","year":"1983","journal-title":"Cell."},{"key":"2020021217460643900_B45","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/sj.onc.1202854","article-title":"Mutation of the 9q34 gene TSC1 in sporadic bladder cancer.","volume":"18","author":"Hornigold","year":"1999","journal-title":"Oncogene."},{"key":"2020021217460643900_B46","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/hmg\/3.10.1833","article-title":"The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor.","volume":"3","author":"Green","year":"1994","journal-title":"Hum Mol Genet."},{"key":"2020021217460643900_B47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-1119(99)00456-4","article-title":"Isolation of genes from the rhabdoid tumor deletion region in chromosome band 22q11.2.","volume":"241","author":"Zhou","year":"2000","journal-title":"Gene."},{"key":"2020021217460643900_B48","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1006\/bbrc.1998.9968","article-title":"Cloning and characterization of a novel Rab-family gene, Rab36, within the region at 22q11.2 that is homozygously deleted in malignant rhabdoid tumors.","volume":"254","author":"Mori","year":"1999","journal-title":"Biochem Biophys Res Commun."},{"key":"2020021217460643900_B49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/(SICI)1098-2264(199805)22:1<26::AID-GCC4>3.0.CO;2-9","article-title":"A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.","volume":"22","author":"Filippova","year":"1998","journal-title":"Genes Chromosomes Cancer."},{"key":"2020021217460643900_B50","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.leu.2401018","article-title":"Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. European 11q23 Workshop participants.","volume":"12","author":"Harbott","year":"1998","journal-title":"Leukemia."},{"key":"2020021217460643900_B51","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2401644","article-title":"Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL).","volume":"14","author":"Lens","year":"2000","journal-title":"Leukemia."},{"key":"2020021217460643900_B52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0959-8049(98)00413-4","article-title":"Allelic imbalance at chromosome region 11q23 in cervical carcinomas.","volume":"35","author":"Skomedal","year":"1999","journal-title":"Eur J Cancer."},{"key":"2020021217460643900_B53","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1038\/sj.onc.1202887","article-title":"Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.","volume":"18","author":"Guo","year":"1999","journal-title":"Oncogene."},{"key":"2020021217460643900_B54","first-page":"1157","volume-title":"Hematology: Basic Principles and Practice.","author":"Hoffman","year":"2000","edition":"3rd ed."},{"key":"2020021217460643900_B55","first-page":"435","volume-title":"Postgraduate Haematology.","author":"Hoffbrand","year":"1999","edition":"4th ed."},{"key":"2020021217460643900_B56"},{"key":"2020021217460643900_B57"},{"key":"2020021217460643900_B58"},{"key":"2020021217460643900_B59"},{"key":"2020021217460643900_B60"},{"key":"2020021217460643900_B61"},{"key":"2020021217460643900_B62"},{"key":"2020021217460643900_B63"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/11\/3581\/1674110\/h8110103581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/11\/3581\/1674110\/h8110103581.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T18:44:11Z","timestamp":1581533051000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/97\/11\/3581\/107454\/Primary-chromosomal-rearrangements-of-leukemia-are"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6,1]]},"references-count":63,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,6,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v97.11.3581","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6,1]]}}}